Article Information
History
- February 26, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Santiago Romero-Brufau1,2,
- Ayush Chopra3,
- Alex J Ryu1,
- Esma Gel4,
- Ramesh Raskar3,
- Walter Kremers5,
- Karen Anderson1,
- Jayakumar Subramanian6,
- Balaji Krishnamurthy6,
- Abhishek Singh3,
- Kalyan Pasupathy5,
- Yue Dong1,
- John C O’Horo1,
- Walter R Wilson1,
- Oscar Mitchell7 and
- Thomas C Kingsley1,*
- 1Department of Medicine, Mayo Clinic, Rochester, MN, USA
- 2Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA
- 3MIT Media Lab, Massachusetts Institute of Technology, Cambridge, MA, USA
- 4School of Computing, Informatics, and Decision Systems Engineering, Arizona State University, AZ, USA
- 5Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA
- 6Media and Data Science Research Lab, Adobe Systems, Newton, MA, USA
- 7Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA
- ↵*Corresponding author:
Thomas C Kingsley email: kingsley.thomas{at}mayo.edu
Author contributions: TCK, EG, RR and SRB conceptualized the study; TCK, SRB and EG designed the study; AC and AS performed the analyses with mentorship from SRB, EG, TCK, JS and BK; SRB, EG, TCK and WK interpreted the results; AJR, TCK, SRB and EG drafted the manuscript; KP, YD, JOH, WW and MO revised the manuscript critically. All authors reviewed and approved the final manuscript.
Posted February 26, 2021.
The Public Health Impact of Delaying a Second Dose of the BNT162b2 or mRNA-1273 COVID-19 Vaccine
